Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Galactorrhea with euprolactinemia under SSRI treatment].

Der Nervenarzt·2025
Same author

Laser driven FLASH radiobiology using a high dose and ultra high dose rate single pulse proton source.

Scientific reports·2025
Same author

Abundant hydrocarbons in the disk around a very-low-mass star.

Science (New York, N.Y.)·2024
Same author

Occupational Therapy Practitioners' Implementation of Home Programs for Individuals Post Burn: An Initial Cross-Sectional Survey.

Occupational therapy in health care·2023
Same author

Water in the terrestrial planet-forming zone of the PDS 70 disk.

Nature·2023
Same author

Measuring spatio-temporal couplings using modal spatio-spectral wavefront retrieval.

Optics express·2023

Related Experiment Video

Updated: Jun 3, 2026

Pseudomonas aeruginosa Induced Lung Injury Model
07:24

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

[Drug-induced lung diseases].

J Schreiber1

  • 1Abteilung für Pneumologie, Universitätsklinikum Magdeburg. jens.schreiber@med.ovgu.de

Deutsche Medizinische Wochenschrift (1946)
|March 25, 2011
PubMed
Summary

Adverse drug reactions can cause various lung diseases, including cough, obstruction, and fibrosis. Identifying these drug-induced lung conditions requires excluding other causes and stopping the offending medication.

Area of Science:

  • Pulmonology
  • Pharmacology
  • Pathology

Context:

  • Adverse drug reactions (ADRs) are a significant cause of morbidity.
  • Drug-induced lung diseases encompass a broad spectrum of respiratory conditions.
  • These conditions can mimic primary pulmonary diseases, complicating diagnosis.

Purpose:

  • To review the diverse range of bronchopulmonary disorders caused by drug therapy.
  • To outline diagnostic approaches for drug-induced lung diseases.
  • To emphasize the importance of drug withdrawal and potential therapeutic interventions.

Summary:

  • Drug therapy can lead to various lung and bronchial disorders, including cough, obstruction, alveolitis, fibrosis, pulmonary edema, and pleural diseases.
  • Diagnosis relies on identifying compatible patterns, excluding other causes, and observing the effects of drug cessation.

More Related Videos

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
11:07

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

Related Experiment Videos

Last Updated: Jun 3, 2026

Pseudomonas aeruginosa Induced Lung Injury Model
07:24

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
11:07

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

  • Strict elimination of the causative drug is the primary treatment, often supplemented with glucocorticosteroids.
  • Impact:

    • Highlights the importance of considering drug-induced etiology in respiratory symptoms.
    • Provides a framework for diagnosing and managing iatrogenic pulmonary conditions.
    • Emphasizes the critical role of pharmacovigilance in respiratory medicine.